Document Detail


Bacterial vaginosis in pregnancy and efficacy of short-course oral metronidazole treatment: a randomized controlled trial.
MedLine Citation:
PMID:  8058228     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To characterize the natural history of bacterial vaginosis in pregnancy and to assess the efficacy of short courses of oral metronidazole therapy for long-term suppression of bacterial vaginosis flora. METHODS: This was a randomized, double-blind, placebo-controlled study of two 2-day courses of metronidazole (400 mg twice daily) in pregnant women with bacterial vaginosis (by Gram stain) and/or heavy growth of Gardnerella vaginalis. The first course was given at 24 weeks' gestation and a second course at 29 weeks if the follow-up vaginal swab grew G vaginalis. Follow-up swabs were performed at 28, 32, and 36 weeks' gestation. RESULTS: On the basis of their G vaginalis colonization, 196 women were enrolled, and 137 were evaluable for efficacy, including 66 with bacterial vaginosis. The microbial ecology of bacterial vaginosis in 36 women in the placebo group was relatively stable, with 72% persistence at 28 weeks and 57% at 32 weeks' gestation. Metronidazole effectively suppressed bacterial vaginosis for 4 weeks after the first course in 76%, compared with 28% in the placebo group, and had a cumulative efficacy of 87% compared to 44% 4 weeks after the second course (odds ratio 0.12, 95% confidence interval 0.03-0.5). CONCLUSIONS: The microbial ecology of bacterial vaginosis in pregnant women is relatively stable. Long-term suppression of bacterial vaginosis flora for 2-3 months can be achieved by short courses of metronidazole therapy in 87% of women in mid-pregnancy. Because bacterial vaginosis has been associated with an increased risk of preterm labor, these findings provide the foundation for an intervention study of women with bacterial vaginosis in pregnancy.
Authors:
H M McDonald; J A O'Loughlin; R Vigneswaran; P T Jolley; P J McDonald
Related Documents :
19840288 - Trends in preterm births in flanders, belgium, from 1991 to 2002.
20618238 - Is there a correlation between bacterial vaginosis and preterm labour in women in the o...
23153898 - Prolonged monitoring of ethinyl estradiol and levonorgestrel levels confirms an altered...
24425198 - Microbiological and physico-chemical quality of various tissue types of fresh and potas...
22246858 - Risk factors for raynaud's phenomenon in the workforce: french pays de la loire study.
19863568 - Urban earthquake hazard: perceived seismic risk and preparedness in dhaka city, banglad...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Obstetrics and gynecology     Volume:  84     ISSN:  0029-7844     ISO Abbreviation:  Obstet Gynecol     Publication Date:  1994 Sep 
Date Detail:
Created Date:  1994-09-09     Completed Date:  1994-09-09     Revised Date:  2009-10-26    
Medline Journal Info:
Nlm Unique ID:  0401101     Medline TA:  Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  343-8     Citation Subset:  AIM; IM    
Affiliation:
Women's and Children's Hospital, Queen Victoria Hospital Campus, Adelaide, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adult
Double-Blind Method
Drug Administration Schedule
Female
Follow-Up Studies
Gardnerella vaginalis*
Humans
Metronidazole / administration & dosage*,  therapeutic use
Pregnancy
Pregnancy Complications, Infectious / drug therapy*,  epidemiology,  microbiology
Time Factors
Vaginosis, Bacterial / drug therapy*,  epidemiology,  microbiology
Chemical
Reg. No./Substance:
443-48-1/Metronidazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of relaxin in the development of the uteroplacental circulation in early pregnancy.
Next Document:  Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive ...